Jiangsu Hengrui Medicine
600276.SS
#434
Rank
NZ$91.54 B
Marketcap
NZ$13.79
Share price
-1.46%
Change (1 day)
28.43%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): NZ$0.21

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is NZ$0.21. In 2024 the company made an earnings per share (EPS) of NZ$0.23 an increase over its 2023 EPS that were of NZ$0.16.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.21-8.7%
2024NZ$0.2342.43%
2023NZ$0.168.77%
2022NZ$0.15-20.62%
2021NZ$0.19-26.59%
2020NZ$0.2527.24%
2019NZ$0.2028.41%
2018NZ$0.1620.04%
2017NZ$0.1331.21%
2016NZ$0.0984811.46%
2015NZ$0.0883636.27%
2014NZ$0.0648419.77%
2013NZ$0.0541418.05%
2012NZ$0.0458623.9%
2011NZ$0.0370126.9%
2010NZ$0.0291712.37%
2009NZ$0.0259656.6%
2008NZ$0.016589.18%
2007NZ$0.01518114.48%
2006NZ$0.00707964.83%
2005NZ$0.00429535.55%
2004NZ$0.00316829.73%
2003NZ$0.00244219.86%
2002NZ$0.002038-2.71%
2001NZ$0.0020941.02%
2000NZ$0.002073